Browsing Tag
autoimmune hemolytic anemia
1 post
Keymed Biosciences’ CM336 shows sustained remission in AIHA patients after CAR-T failure
Keymed Biosciences’ CM336 delivers 6-month remission in AIHA post-CAR-T failure, with NEJM publication and bullish stock sentiment. Find out what’s next for the biotech.